Templeman Blaine 4
4 · ADURO BIOTECH, INC. · Filed Nov 17, 2017
Insider Transaction Report
Form 4
Templeman Blaine
Executive VP, General Counsel
Transactions
- Sale
Common Stock
2017-11-17$8.85/sh−243$2,151→ 58,834 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were affected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2016.
- [F2]Includes 243 shares acquired by the Reporting Person under the Issuer's 2015 Employee Stock Purchase Plan on November 15, 2017.